DAFNA Capital Management LLC - PHASEBIO PHARMACEUTICALS INC ownership

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 61 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$9,688
-83.0%
321,8560.0%0.00%
-80.0%
Q3 2022$57,000
-74.9%
321,856
-15.0%
0.02%
-75.8%
Q2 2022$227,000
-54.6%
378,6110.0%0.06%
-52.3%
Q1 2022$500,000
-49.4%
378,6110.0%0.13%
-47.6%
Q4 2021$988,000
-47.3%
378,611
-37.2%
0.25%
-50.1%
Q3 2021$1,875,000
-16.4%
603,0420.0%0.50%
+6.0%
Q2 2021$2,243,000
+7.5%
603,0420.0%0.47%
-5.3%
Q1 2021$2,087,000
+93.8%
603,042
+88.1%
0.50%
+54.7%
Q4 2020$1,077,000
-4.3%
320,5420.0%0.32%
-12.6%
Q3 2020$1,125,000
-23.7%
320,5420.0%0.37%
-13.9%
Q2 2020$1,474,000
+38.9%
320,5420.0%0.42%
-4.1%
Q1 2020$1,061,000
-51.8%
320,542
-11.1%
0.44%
-41.4%
Q4 2019$2,203,000
+46.6%
360,5420.0%0.76%
+33.8%
Q3 2019$1,503,000
-42.7%
360,542
+80.3%
0.56%
-42.7%
Q2 2019$2,624,000
+280.8%
200,013
+175.9%
0.99%
+232.0%
Q1 2019$689,000
+123.0%
72,500
-27.5%
0.30%
+92.9%
Q4 2018$309,000100,0000.15%
Other shareholders
PHASEBIO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 1,607,044$4,194,0000.48%
NEA Management Company, LLC 6,643,704$17,340,0000.35%
Platform Technology Partners 251,723$657,0000.29%
DAFNA Capital Management LLC 378,611$988,0000.25%
Avidity Partners Management LP 4,405,000$11,497,0000.24%
Endurant Capital Management LP 360,078$940,0000.23%
Rock Springs Capital Management LP 2,581,299$6,737,0000.16%
RA Capital Management 2,850,000$7,439,0000.13%
New Legacy Group, LLC 240,575$628,0000.12%
XTX Topco Ltd 15,574$41,0000.02%
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders